Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;65(6):1572-9.
doi: 10.1086/302651.

Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B

Affiliations

Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B

P M Green et al. Am J Hum Genet. 1999 Dec.

Abstract

A population-based study of hemophilia B mutations was conducted in the United Kingdom in order to construct a national confidential database of mutations and pedigrees to be used for the provision of carrier and prenatal diagnoses based on mutation detection. This allowed the direct estimate of overall (micro), male (v), and female (u) mutation rates for hemophilia B. The values obtained per gamete per generation and the 95% confidence intervals are micro;=7.73 (6. 29-9.12&parr0;x10-6; v=18.8 (14.5-22.9&parr0;x10-6; and u=2.18 (1. 44-3.16&parr0;x10-6. The ratio of male-to-female mutation rates is 8. 64, with a 95% confidence interval of 5.46-14.5. The higher male rate was not caused by a much higher rate of transition at CpG sites in the male. Attempts to detect evidence of gonadal mosaicism for hemophilia B mutation in suitable families did not detect any instances of ovarian mosaicism in any of 47 available opportunities. This suggests that the risk of a noncarrier mother manifesting as a gonadal mosaic by transmitting the mutation to a second child should be <0.062.

PubMed Disclaimer

Similar articles

Cited by

References

Electronic-Database Information

    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim (for hemophilia A [MIM 30670], hemophilia B [MIM 30690], Duchenne muscular dystrophy [MIM 31020], and ornithine transcarbamylase deficiency [MIM 31125])

References

    1. Anson DS, Choo KH, Rees DJG, Giannelli F, Gould K, Huddleston JA, Brownlee GG (1984) The gene structure of human anti-haemophilic factor IX. EMBO J 3:1053–1060 - PMC - PubMed
    1. Becker J, Schwaab R, Möller-Taube A, Schwaab U, Schmidt W, Brackmann HH, Grimm T, et al (1996) Characterization of the factor VIII defect of 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet 58:657–670 - PMC - PubMed
    1. Chen JX, Zheng Y, West M, Tang M-S (1998) Carcinogens preferentially bind at methylated CpG in the p53 mutational hotspot. Cancer Res 58:2070–2075 - PubMed
    1. Giannelli F, Green PM (1996) The molecular basis of haemophilia A and B. In: Lee CA (ed) Baillière's clinical haematology. Vol 9: Haemophilia. Baillière Tindall, London, pp 211–228 - PubMed
    1. Giannelli F, Saad S, Anagnostopoulos T, Green PM (1999) Mutation rates in man. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from haemophilia B. Am J Hum Genet 65:1580–1587 (in this issue) - PMC - PubMed

Publication types

LinkOut - more resources